This HTML5 document contains 118 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50668343
rdf:type
wikibase:Item
schema:description
научни чланак artigo científico wissenschaftlicher Artikel vitskapeleg artikkel мақолаи илмӣ научна статия 2011年学术文章 2011年学术文章 บทความทางวิทยาศาสตร์ tieteellinen artikkeli 2011年學術文章 artikull shkencor scientific article published on 10 October 2011 2011年學術文章 artículu científicu articol științific наукова стаття, опублікована в жовтні 2011 2011年学术文章 vetenskaplig artikel bài báo khoa học научни чланак מאמר מדעי artykuł naukowy scienca artikolo artigo científico 2011년 논문 article scientifique artikel ilmiah 2011年學術文章 2011年の論文 journal article published in 2011 teaduslik artikkel 2011年学术文章 2011 nî lūn-bûn vedecký článok 2011年學術文章 tudományos cikk artigo científico vědecký článek مقالة علمية نشرت في 10 أكتوبر 2011 naučni članak 2011 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված bilimsel makale article scientific wetenschappelijk artikel ১০ অক্টোবর ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2011年学术文章 article científic 2011年學術文章 videnskabelig artikel научная статья სამეცნიერო სტატია scientific article published on 10 October 2011 artículo científico publicado en 2011 vitenskapelig artikkel articolo scientifico artikulong pang-agham 2011年学术文章 επιστημονικό άρθρο
p:P577
wds:Q50668343-A5C26468-A73B-415A-B9F4-50EC3152BD71 wds:Q50668343-7C57E7D8-2FE1-4B93-B0A2-C822BB4A4E3E
wdt:P577
2011-10-10T00:00:00Z 2011-12-01T00:00:00Z
p:P407
wds:Q50668343-C7B7D030-27B5-4B22-8B5D-AB53E70EA464
wdt:P407
wd:Q1860
p:P2093
wds:Q50668343-3AC00F54-942F-45D0-A0A6-9E11D00074F7 wds:Q50668343-239BE4D2-6111-4135-A730-837083E2A28C wds:Q50668343-0AC10ACD-3CBD-4887-BA34-44C72D10982F wds:Q50668343-C035C272-94A4-4EEB-861B-1867A7AEE8A8 wds:Q50668343-93340DAE-B158-45C4-B5C3-6654CEDD3E19 wds:Q50668343-7089A897-707F-4F59-B88B-E6B0D4FFBDE2
wdt:P2093
Chad J Gwaltney Nancy Kline Leidy Lena Ring Elizabeth Molsen Mona L Martin Laurie B Burke
rdfs:label
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.
skos:prefLabel
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.
schema:name
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.
p:P50
wds:Q50668343-40F316D3-A4F4-4CAB-B2FA-635276B4B5F7
wdt:P50
wd:Q78737102
p:P1476
wds:Q50668343-2DECE080-1290-435D-B4CD-943AE92A4FB6 wds:Q50668343-48528444-B56D-424A-AFDA-ACCFA9496A3D
wdt:P1476
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2--assessing respondent understanding
p:P304
wds:Q50668343-03A1E88B-FB57-4757-B3FC-B178D62DBC5F
wdt:P304
978-988
p:P31
wds:Q50668343-610101B0-11A6-4FA2-AED4-77A2CF2B9294
wdt:P31
wd:Q13442814
p:P698
wds:Q50668343-C17CACDC-55AE-4F2B-8B91-37CCED6F5D8B
wdtn:P698
n12:22152166
wdt:P698
22152166
p:P1433
wds:Q50668343-EBDE3F38-C919-4AAE-9C80-7EED111BBF42
wdt:P1433
wd:Q15766908
p:P433
wds:Q50668343-402BF07D-8C63-460A-B7AB-C8B3EC820744
p:P478
wds:Q50668343-6FBFBAA3-D76E-4E99-AF62-207E8B807F93
wdt:P433
8
wdt:P478
14
p:P6195
wds:Q50668343-68E10310-05A5-420B-B1B6-6B125CCFD2FC
wdt:P6195
wd:Q230788
p:P356
wds:Q50668343-AD80AC10-F3C6-4348-8F42-6CDD8E60BC98
wdtn:P356
n9:J.JVAL.2011.06.013
wdt:P356
10.1016/J.JVAL.2011.06.013
skos:altLabel
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2--assessing respondent understanding
p:P5008
wds:Q50668343-C0F421CF-63EF-4533-94F0-5E5F64917059
p:P859
wds:Q50668343-6005721B-AF45-407D-99B4-67FC6E841577
wdt:P5008
wd:Q104416361
wdt:P859
wd:Q60346
p:P8608
wds:Q50668343-B122EFFC-43E0-489B-A9BF-4010B2F67583
wdt:P8608
release_jhkzqbnvarfernl5aikoimzlma
p:P5875
wds:Q50668343-48C2ED8D-5FDD-4EFE-B349-C67FA4391752
wdt:P5875
51862399
p:P12526
wds:Q50668343-98ACF8B0-BD74-41EF-9B29-39D9C48887B2
p:P2880
wds:Q50668343-82EF271F-DB82-4928-A7DC-134D94637E6F
wdt:P12526
wd:Q219563
wdt:P2880
20057076